Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients
Lan Gong(Chinese Academy of Medical Sciences & Peking Union Medical College), Albert Elion‐Mboussa, Linnong Wang, Yangshun Gu(First Affiliated Hospital Zhejiang University), Mingzhi Zhang(Chinese Academy of Sciences), Lipika Roy, Xinghuai Sun(Shanghai Medical College of Fudan University), Hong Zhang(Fudan University), Jia Qu(Dongguan University of Technology), Lili Wang(Hunan Agricultural University)
Cited by 24
Related Papers
Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Efficacy Comparison of 16 Interventions for Myopia Control in Children
|Ophthalmology|2016|756
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
|Proceedings of the National Academy of Sciences|2009|322
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
|Canadian Medical Association Journal|2013|307
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296